Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9797693 | 0.86 | KCNJ1 (0.41) | HDAC8 | |
| SCHEMBL934260 | 0.84 | — | — | |
| SCHEMBL17843148 | 0.84 | — | — | |
| SCHEMBL30771589 | 0.84 | — | — | |
| SCHEMBL1107417 | 0.84 | — | — | |
| SCHEMBL3663922 | 0.78 | TRPV4 (0.39) | — | |
| SCHEMBL21508908 | 0.78 | KDM4E (0.32) | HDAC8 | |
| Ligustrazine SCHEMBL29236276 | 0.76 | HDAC8 (0.31) | HDAC8 | |
| SCHEMBL20920765 | 0.75 | — | — | |
| SCHEMBL5042238 | 0.75 | SIRT6 (0.52) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130287700-A1 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | KLINIKUM DARMSTADT GMBH (DE) | 2013-10-31 | — | — | US | claimed |
| EP-2619591-A2 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | Technische Universität Darmstadt (DE) | 2013-07-31 | — | — | EP | claimed |
| EP-2619590-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | Technische Universität Darmstadt (DE) | 2013-07-31 | — | — | EP | claimed |
| WO-2013041522-A1 | METHODS AND DEVICES FOR THE DETECTION OF TAU PROTEIN DEPOSITS IN EYES | CARL ZEISS AG (DE) | 2013-03-28 | — | — | WO | claimed |
| WO-2012041292-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | KLINIKUM DARMSTADT GMBH (DE) | 2012-04-05 | — | — | WO | claimed |
| WO-2012037928-A2 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | KLINIKUM DARMSTADT GMBH (DE) | 2012-03-29 | — | — | WO | claimed |
| CN-1186330-C | Polymerizable hydrophilio ultraviolet light absorbing manomers | PHARMACIA & UPJOHN BV (NL) | 2005-01-26 | — | — | CN | claimed |
| EP-1077952-B1 | POLYMERIZABLE HYDROPHILIC ULTRAVIOLET LIGHT ABSORBING MONOMERS | PHARMACIA & UPJOHN BV (NL) | 2003-11-12 | — | — | EP | claimed |
| EP-0889916-B1 | HIGH REFRACTIVE INDEX HYDROGELS PREPARED FROM POLYMERS AND COPOLYMERS OF N-BENZYL-N-METHYLACRYLAMIDE | UPJOHN CO (US) | 2003-05-07 | — | — | EP | claimed |
| CN-1103786-C | High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide | PHARMACIA IOVISION INC (US) | 2003-03-26 | — | — | CN | claimed |
| EP-1077952-A1 | POLYMERIZABLE HYDROPHILIC ULTRAVIOLET LIGHT ABSORBING MONOMERS | Pharmacia & Upjohn Groningen BV (NL) | 2001-02-28 | — | — | EP | claimed |
| EP-0889916-A4 | HIGH REFRACTIVE INDEX HYDROGELS PREPARED FROM POLYMERS AND COPOLYMERS OF N-BENZYL-N-METHYLACRYLAMIDE | PHARMACIA IOVISION INC (US) | 2000-06-28 | — | — | EP | claimed |
| US-6036891-A | 2-(2'-HYDROXY-5'-(METH)ACRYLOXYALKOXYALKYLPHENYL)-2H-BENZOTRIAZOLE MONOMERS WHICH FORM OPTICALLY CLEAR ULTRAVIOLET LIGHT ABSORBING HYDROGELS USEFUL IN INTRAOCULAR LENSES, CONTACT LENSES | PHARMACIA & UPJOHN (US) | 2000-03-14 | — | — | US | claimed |
| WO-1999058507-A1 | POLYMERIZABLE HYDROPHILIC ULTRAVIOLET LIGHT ABSORBING MONOMERS | PHARMACIA & UPJOHN GRONINGEN B.V. (NL) | 1999-11-18 | — | — | WO | claimed |
| CN-1219179-A | High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide | PHARMACIA IOVISION INC (US) | 1999-06-09 | — | — | CN | claimed |
| EP-0889916-A1 | HIGH REFRACTIVE INDEX HYDROGELS PREPARED FROM POLYMERS AND COPOLYMERS OF N-BENZYL-N-METHYLACRYLAMIDE | Pharmacia Iovision Inc. (US) | 1999-01-13 | — | — | EP | claimed |
| US-5717049-A | INTRAOCULAR LENSES | PHARMACIA IOVISION, INC. (US) | 1998-02-10 | — | — | US | claimed |
| WO-1997035896-A1 | HIGH REFRACTIVE INDEX HYDROGELS PREPARED FROM POLYMERS AND COPOLYMERS OF N-BENZYL-N-METHYLACRYLAMIDE | PHARMACIA IOVISION INC. (US) | 1997-10-02 | — | — | WO | claimed |
| WO-1996000248-A1 | WATER MISCIBLE NON-HYDROLYZABLE CROSS-LINKERS AND HIGH REFRACTIVE INDEX HYDROGELS PREPARED THEREWITH | KABI PHARMACIA OPHTHALMICS, INC. (US) | 1996-01-04 | — | — | WO | claimed |
| US-5439950-A | Intraocular lenses | KABI PHARMACIA OPHTHALMICS, INC. (US) | 1995-08-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130287700-A1 | COMPOUNDS FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISORDERS ON THE OLFACTORY EPITHELIUM | SNCA, MAPT, TARDBP | HDAC8 4540/4885ALDH1A1 1165/4885MAPT 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.